These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome]. Tegaserod Clinical Research Group. Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702 [Abstract] [Full Text] [Related]
4. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P. Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489 [Abstract] [Full Text] [Related]
6. Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups. Zar S, Benson MJ, Kumar D. Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):151-8. PubMed ID: 16394796 [Abstract] [Full Text] [Related]
7. Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome. Coffin B, Bouhassira D, Sabaté JM, Barbe L, Jian R. Gut; 2004 Oct; 53(10):1465-70. PubMed ID: 15361496 [Abstract] [Full Text] [Related]
8. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Evans BW, Clark WK, Moore DJ, Whorwell PJ. Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003960. PubMed ID: 17943807 [Abstract] [Full Text] [Related]
15. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Neurogastroenterol Motil; 2007 Oct 17; 19(10):821-30. PubMed ID: 17539894 [Abstract] [Full Text] [Related]
16. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA. Am J Gastroenterol; 2008 May 17; 103(5):1217-25. PubMed ID: 18477346 [Abstract] [Full Text] [Related]
17. Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women. Wagstaff AJ, Frampton JE, Croom KF. Drugs; 2003 May 17; 63(11):1101-20. PubMed ID: 12749744 [Abstract] [Full Text] [Related]
18. [Investigation of visceral hyperesthesia in irritable bowel syndrome]. Király A, Csizmadia C, Illés A, Undi S. Orv Hetil; 2006 Mar 05; 147(9):421-6. PubMed ID: 16619961 [Abstract] [Full Text] [Related]